Trademark: HOPE SOCIETY A DIVISION OF INTERNATIONAL MYELOMA FOUNDATION
Put your brand on the blockchain and timestamp its proof of existence at wikitrademarks.io
Track updates on HOPE SOCIETY A DIVISION OF INTERNATIONAL MYELOMA FOUNDATION
Mark Identification
HOPE SOCIETY A DIVISION OF INTERNATIONAL MYELOMA FOUNDATION
Proof of use for HOPE SOCIETY A DIVISION OF INTERNATIONAL MYELOMA FOUNDATION
We do not have any records of a proof of use for HOPE SOCIETY A DIVISION OF INTERNATIONAL MYELOMA FOUNDATION at this moment.
Click here to add a proof of use for HOPE SOCIETY A DIVISION OF INTERNATIONAL MYELOMA FOUNDATION
Possible trademark infringements of HOPE SOCIETY A DIVISION OF INTERNATIONAL MYELOMA FOUNDATION
Basic Information about HOPE SOCIETY A DIVISION OF INTERNATIONAL MYELOMA FOUNDATION
- Serial Number
- 87799526
- Filing Date
- 15 Feb 2018
- Registration Number
- 5758762
- Registration Date
- 21 May 2019
- Mark Drawing Code
- 3
Classifications
Declare the trademark use of HOPE SOCIETY A DIVISION OF INTERNATIONAL MYELOMA FOUNDATION on the blockchain with WikiTrademarks.io.
- First use of HOPE SOCIETY A DIVISION OF INTERNATIONAL MYELOMA FOUNDATION anywhere
- HOPE SOCIETY A DIVISION OF INTERNATIONAL MYELOMA FOUNDATION was first used on 12 Oct 2018 for the primary classification of goods and services, international, 036 (Insurance and financial)
- First use in commerce
- There is no first use of this trademark in commerce detected yet.
- Status Code
- 6
- International Code
- 036
- US Codes
- 100; 101; 102
Who owns HOPE SOCIETY A DIVISION OF INTERNATIONAL MYELOMA FOUNDATION?
1. International Myeloma Foundation Studio City CA
2. International Myeloma Foundation North Hollywood CA
3. International Myeloma Foundation North Hollywood CA
Correspondent
- Natasha Shabani GREENBERG GLUSKER FIELDS CLAMAN & MACHTINGER LLP
- 2049 Century Park East
- Suite 2600
- Los Angeles, CA 90067
Put your brand on the blockchain and timestamp its proof of existence at Wikitrademarks.io
Track updates on HOPE SOCIETY A DIVISION OF INTERNATIONAL MYELOMA FOUNDATION